Opportunity Information: Apply for RFA CK 12 002
Apply for RFA CK 12 002
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Detecting Emerging Vector Borne Zoonotic Pathogens in Indonesia" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Feb 15, 2012 and posted on Feb 15, 2012.
- Applicants must submit their applications by Mar 16, 2012 by 500 PM U.S. Eastern Time. On time submission requires that electronic applications be error free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 500 PM U.S. Eastern Time. Note HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $625,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $625,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility is limited to two organizations with the ability to provide administrative oversight and transfer funding to a key laboratory (Eijkman Institute (EI) for Molecular Biology, located in Jakarta, Indonesia) that has the capacity to rapidly and accurately identify arboviral etiologies of acute febrile illness, including those with hemorrhagic and neurological symptoms. The eligible applicant organizations are identified as 1) CRDF Global (Based in Arlington, Virginia with offices in Moscow, Russia Kyiv, Ukraine Almaty, Kazakhstan and Amman, Jordan) 2) Alliance for Emerging Re Emerging Threats in Asia (ALERT) Foundation (based in Jakarta, Indonesia)
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Detecting Emerging Vector Borne Zoonotic Pathogens in Indonesia" (Funding Opportunity Number RFA CK 12 002) is a CDC discretionary funding announcement focused on public health capacity building in Indonesia. Structured as a cooperative agreement, it is meant to support hands-on collaboration with CDC rather than a simple pass-through award, with an overall goal of improving Indonesia's ability to detect and identify emerging vector-borne zoonotic pathogens, particularly those responsible for acute febrile illnesses that can present with severe outcomes such as hemorrhagic or neurological symptoms.
Funding is limited and targeted. CDC anticipated making a single award, with an estimated total funding amount of $625,000. The award ceiling is $625,000 and the award floor is $100,000. There is no cost sharing or matching requirement, which means the recipient is not required to provide additional non-federal funds to match the award as a condition of receiving the grant.
A central feature of this opportunity is that eligibility is restricted to two specific organizations that can provide administrative oversight and, importantly, transfer funding to a key implementing laboratory in Indonesia: the Eijkman Institute (EI) for Molecular Biology in Jakarta. EI is identified in the announcement as having the capacity to rapidly and accurately identify arboviral causes of acute febrile illness, including cases with hemorrhagic and neurologic manifestations. The two eligible applicant organizations are: (1) CRDF Global, based in Arlington, Virginia (with offices in multiple international locations), and (2) the Alliance for Emerging/Re-Emerging Threats in Asia (ALERT) Foundation, based in Jakarta, Indonesia. In practice, this framing indicates that CDC intended the award to flow through one of these organizations to support EI's laboratory-related detection work, while ensuring strong administrative controls and oversight.
The application timeline was short and specific. The opportunity was posted and created on February 15, 2012, with an original and current closing date of March 16, 2012 at 5:00 PM U.S. Eastern Time, and it was archived on March 17, 2012. Applications had to be submitted electronically through Grants.gov and validated through eRA Commons by the deadline. The notice emphasizes that submissions needed to be error-free and fully available to CDC for processing by the cutoff time, and that CDC/HHS procedures did not provide an "error correction window" after the deadline. In other words, late fixes for system-identified errors were not permitted beyond the due date, so applicants were expected to complete submission and validation well before the deadline to avoid disqualification due to technical issues.
Administratively, the award falls under CFDA 93.283, described as "Centers for Disease Control and Prevention Investigations and Technical Assistance," and the activity category is Health. For applicants needing help accessing the full announcement, the posting provides CDC Procurement and Grants Office contact details through the Technical Information and Management Section (TIMS), including a general inquiry phone number (770-488-2700).
Overall, the opportunity is best understood as a tightly scoped CDC cooperative agreement designed to bolster Indonesia's early detection and identification capacity for emerging vector-borne zoonotic threats by supporting a proven laboratory hub (the Eijkman Institute) through one of two pre-designated administrative partner organizations, with a single award and a total funding level capped at $625,000.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Detecting Emerging Vector Borne Zoonotic Pathogens in Indonesia" and the Funding Opportunity Number is RFA CK 12 002.
Which federal agency is offering this opportunity?
This is a CDC (Centers for Disease Control and Prevention) discretionary funding announcement.
What type of award is this?
It is structured as a cooperative agreement. That means the project is intended to involve hands-on collaboration with CDC, rather than operating as a simple pass-through grant with minimal federal involvement.
What is the overall purpose of the award?
The overall goal is to improve Indonesia's ability to detect and identify emerging vector-borne zoonotic pathogens, with a particular focus on pathogens that cause acute febrile illnesses and can present with severe outcomes such as hemorrhagic or neurological symptoms.
What kinds of illnesses or threats are emphasized in the announcement?
The announcement highlights emerging vector-borne zoonotic pathogens, especially those responsible for acute febrile illness, including cases that may involve hemorrhagic manifestations or neurologic manifestations.
How many awards did CDC expect to make?
CDC anticipated making a single award under this funding opportunity.
How much funding was available?
The estimated total funding amount was $625,000.
What is the award ceiling and award floor?
The award ceiling was $625,000 and the award floor was $100,000.
Is cost sharing or matching required?
No. There was no cost sharing or matching requirement, meaning the recipient was not required to contribute non-federal funds as a condition of receiving the award.
Who was eligible to apply?
Eligibility was restricted to two specific organizations: (1) CRDF Global (Arlington, Virginia), and (2) the Alliance for Emerging/Re-Emerging Threats in Asia (ALERT) Foundation (Jakarta, Indonesia).
Why was eligibility limited to these organizations?
Based on the announcement, the eligible organizations were expected to provide administrative oversight and transfer funding to a key implementing laboratory in Indonesia (the Eijkman Institute for Molecular Biology in Jakarta). The structure reflects CDC's intent to support the implementing laboratory while maintaining strong administrative controls and oversight through one of the two designated partners.
Which organization in Indonesia was identified as the key implementing laboratory?
The Eijkman Institute (EI) for Molecular Biology in Jakarta was identified as the key implementing laboratory.
What capability of the Eijkman Institute is specifically noted?
EI is described as having the capacity to rapidly and accurately identify arboviral causes of acute febrile illness, including cases with hemorrhagic and neurologic manifestations.
When was the opportunity posted and created?
The opportunity was posted and created on February 15, 2012.
What was the application deadline?
The original and current closing date was March 16, 2012 at 5:00 PM U.S. Eastern Time.
When was the opportunity archived?
The opportunity was archived on March 17, 2012.
How were applications required to be submitted?
Applications had to be submitted electronically through Grants.gov and validated through eRA Commons by the deadline.
Did applicants have an error-correction window after the deadline?
No. The notice emphasizes that CDC/HHS procedures did not provide an "error correction window" after the deadline. Submissions needed to be error-free and fully available to CDC for processing by the cutoff time.
What did CDC mean by needing submissions to be fully available by the cutoff time?
The announcement indicates that by the deadline, the application had to be successfully submitted and validated (including system checks), without outstanding errors that would prevent CDC from processing it.
What is the CFDA number for this opportunity?
The award falls under CFDA 93.283, described as "Centers for Disease Control and Prevention Investigations and Technical Assistance."
What is the activity category for this funding opportunity?
The activity category is Health.
Who can be contacted for help accessing the full announcement?
The posting provides CDC Procurement and Grants Office contact details through the Technical Information and Management Section (TIMS), including a general inquiry phone number: 770-488-2700.
What is the main takeaway about how the project was intended to be implemented?
The opportunity is described as a tightly scoped CDC cooperative agreement designed to bolster Indonesia's early detection and identification capacity for emerging vector-borne zoonotic threats by supporting a proven laboratory hub (the Eijkman Institute) through one of two pre-designated administrative partner organizations, with a single award capped at $625,000.
Browse more opportunities from the same category: Health
Next opportunity: Learning Center of the American Southwest Website Support
Previous opportunity: Conformance with the Manufactured Food Regulatory Program Standards (MFRPS) (U18)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 12 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 12 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Delivering Therapeutics to Residual Active HIV Reservoirs (R01) Apply for PA 12 107 Funding Number: PA 12 107 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health Systems Strengthening Project Apply for RFA 668 12 000001 Funding Number: RFA 668 12 000001 Agency: Sudan USAID Khartoum Category: Health Funding Amount: $25,000,000 |
| Assays for High Throughput Screening (HTS) to Discover Chemical Probes in the Molecular Libraries Probe Production Centers Network (MLPCN) (X01) Apply for PAR 12 108 Funding Number: PAR 12 108 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhancing Engagement and Retention in Quality HIV Care for Transgender Women of Color Demonstration Sites Apply for HRSA 12 099 Funding Number: HRSA 12 099 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Enhancing Engagement and Retention in Quality HIV Care for Transgender Women of Color Evaluation and Technical Assistance Center Apply for HRSA 12 101 Funding Number: HRSA 12 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Comprehensive Geriatric Education Program (CGEP) Apply for HRSA 12 004 Funding Number: HRSA 12 004 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Regional HIV/AIDS Prevention and Care Project in West Africa Apply for RFA 624 12 000002 Funding Number: RFA 624 12 000002 Agency: Ghana USAID Accra Category: Health Funding Amount: $13,000,000 |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R01) Apply for RFA MH 13 030 Funding Number: RFA MH 13 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R21) Apply for RFA MH 13 031 Funding Number: RFA MH 13 031 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Targeting Persistent HIV Reservoirs (TaPHIR) (R21/R33) Apply for PAR 12 109 Funding Number: PAR 12 109 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44) Apply for RFA HL 13 016 Funding Number: RFA HL 13 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening Safe Hospitals and Clinics in HIV/AIDS Prevention Activities, Services, and Practices in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) CGH/DGHA/Mozambique Apply for CDC RFA PS09 90504CONT12 Funding Number: CDC RFA PS09 90504CONT12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening Capacity through Improved Management and Coordination of Laboratory, Surveillance, Epidemiology Public Health Evaluations and Training in Uganda under PEPFAR Apply for CDC RFA GH12 1212 Funding Number: CDC RFA GH12 1212 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
| Strengthening Human Resource and Institutional Capacity for Delivery of Quality HIV/AIDS, Sexually Transmitted Infection (STI) and Tuberculosis (TB) Services in Local Universities and Surrounding Catchment Areas in Eastern Ethiopia as Part of the Pre Apply for CDC RFA GH12 1221 Funding Number: CDC RFA GH12 1221 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $142,520 |
| Getting from Genes to Function in Lung Disease (R01) Apply for PA 12 110 Funding Number: PA 12 110 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Part C Capacity Development Program Apply for HRSA 12 077 Funding Number: HRSA 12 077 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| Infrastructure Development Program in Patient Centered Outcomes Research (PCOR) (R24) Apply for PA 12 114 Funding Number: PA 12 114 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $250,000 |
| Rural Health Research Center Cooperative Agreement Apply for HRSA 12 164 Funding Number: HRSA 12 164 Agency: Health Resources and Services Administration Category: Health Funding Amount: $660,000 |
| Telehealth Network Grant Program Apply for HRSA 12 092 Funding Number: HRSA 12 092 Agency: Health Resources and Services Administration Category: Health Funding Amount: $250,000 |
| Telehealth Resource Center Grant Program Apply for HRSA 12 097 Funding Number: HRSA 12 097 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 12 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.